Interleukin-5 (IL-5) is a cytokine primarily involved in the growth, differentiation, and activation of eosinophils, playing a crucial role in the immune response and in the pathogenesis of allergic diseases such as asthma. Targeting IL-5 with monoclonal antibodies has become a therapeutic strategy for treating eosinophilic disorders by reducing eosinophil levels and activity.